Anebulo Pharmaceuticals, Inc. (ANEB): Price and Financial Metrics
ANEB Price/Volume Stats
| Current price | $2.71 | 52-week high | $4.05 |
| Prev. close | $2.68 | 52-week low | $1.62 |
| Day low | $2.70 | Volume | 700 |
| Day high | $2.71 | Avg. volume | 5,391 |
| 50-day MA | $2.73 | Dividend yield | N/A |
| 200-day MA | $2.59 | Market Cap | 69.47M |
ANEB Stock Price Chart Interactive Chart >
Anebulo Pharmaceuticals, Inc. (ANEB) Company Bio
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients suffering from cannabinoid overdose and addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
Latest ANEB News From Around the Web
Below are the latest news stories about ANEBULO PHARMACEUTICALS INC that investors may wish to consider to help them evaluate ANEB as an investment opportunity.
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent UpdatesAUSTIN, Texas, November 14, 2023--Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates |
Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn SituationEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... |
Are Medical Stocks Lagging Anebulo Pharmaceuticals (ANEB) This Year?Here is how Anebulo Pharmaceuticals, Inc. (ANEB) and Conmed (CNMD) have performed compared to their sector so far this year. |
Anebulo Pharmaceuticals Announces New CEOAUSTIN, Texas, October 06, 2023--Anebulo Pharmaceuticals Announces New CEO |
Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of DirectorsAUSTIN, Texas, October 06, 2023--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) ("Anebulo"), today announced the appointment of Bimal Shah to its Board of Directors. Mr. Shah will serve as a member of the board’s audit and compensation committees. |
ANEB Price Returns
| 1-mo | 8.51% |
| 3-mo | 12.92% |
| 6-mo | 17.75% |
| 1-year | -3.21% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 11.98% |
| 2023 | -0.15% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...